Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Mitochondria Transplantation Facilitates Neuronal Survival and Neurite Outgrowth - Implication for Glaucoma Therapy
Author Affiliations & Notes
  • Ajay Ashok
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Wai Lydia Tai
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Anton Lennikov
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Sarita Pooranawattanakul
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Karen Chang
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Shuhong Jiang
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Kasim Gunes
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Histology and Embryology, Marmara Universitesi, Istanbul, Istanbul, Turkey
  • Kin-Sang Cho
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Dongfeng Chen
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Ajay Ashok Ingenia Therapeutics, Code F (Financial Support), Schepens Eye Research Institute/MEE, Code P (Patent); Wai Lydia Tai None; Anton Lennikov iLumen Inc, Code F (Financial Support), Schepens Eye Research Institute, Code P (Patent); Sarita Pooranawattanakul None; Karen Chang None; Shuhong Jiang FireCyte Therapeutics, Code C (Consultant/Contractor); Kasim Gunes None; Kin-Sang Cho FireCyte Therapeutics, Biocytogen, Code C (Consultant/Contractor); Dongfeng Chen i-Lumen Scientific, Sichuan PriMed, Cytodigm, Code C (Consultant/Contractor), i-Lumen, Ingenia Therapeutics, Code F (Financial Support), SAB-FireCyte Therapeutics, Code I (Personal Financial Interest), Schepens Eye Research Institute/MEE, Code P (Patent)
  • Footnotes
    Support  NIH/NEI EY031696; EY033882; Core Grant for Vision Research from NIH/NEI to the Schepens Eye Research Institute (P30EY003790), Harvard NeuroDiscovery Center Grant
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3447. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ajay Ashok, Wai Lydia Tai, Anton Lennikov, Sarita Pooranawattanakul, Karen Chang, Shuhong Jiang, Kasim Gunes, Kin-Sang Cho, Dongfeng Chen; Mitochondria Transplantation Facilitates Neuronal Survival and Neurite Outgrowth - Implication for Glaucoma Therapy. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3447.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Mitochondrial dysfunction is associated with neurodegenerative diseases, including glaucoma, a leading cause of irreversible blindness worldwide. It is thought to be a key contributing factor to retinal ganglion cell (RGC) loss in glaucoma. Meeting the energy needs of diseased RGCs by replenishing active mitochondrial levels through mitochondrial transplantation may hold a promise for neuroprotective and regenerative medicine. In our current research work, we tested the efficacy of transplanted mitochondria in facilitating neuronal survival and axonal outgrowth in cultured neurons.

Methods : Mitochondria homeostasis in RGCs isolated from 3-month and 12-month old mice were evaluated by quantitative polymerase chain reaction (qPCR) to assess the levels of mitochondria associated genes. PC12 cells (from ATCC) were induced to differentiate using nerve growth factor (NGF); mitochondrial function was measured using Seahorse Analytics. Mitochondria were isolated from PC12 cells, stained using MitoTracker™ Red, and transplanted to cultured PC12 cells using Mitoception. Endogenous mitochondria were stained using MitoTracker™ Green FM. PC12 cell neurite outgrowth was evaluated at day 6-10 post transplantation, using Leica fluorescent microscope and EVOS M7000 Imaging System.

Results : qPCR revealed a significant decrease in levels of PINK1 (gene involved in mitochondrial quality control) in aging RGCs, implicating mitochondrial homeostatic dysfunction in aging RGCs. A marked increase in mitochondrial function was observed following NGF treatment in PC12 cells, suggesting an active role of mitochondrial dynamics in neuronal differentiation and neurite outgrowth. Effective mitochondrial uptake by PC12 cells were validated using MitoTracker™ intensity analysis in cells. Significantly increased number and average length of neurites and sustained neurite outgrowth were observed in differentiating PC12 cells following mitochondria transplantation. Transplanted mitochondria were seen to transport along the neuronal processes all the way to the growth cones.

Conclusions : Our results point to a dynamic role of mitochondria in neuronal differentiation and neurite outgrowth. Mitochondrial transplantation can pave the way to design effective therapeutics to address glaucoma induced neuronal degeneration.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×